Prostate Cancer Screening Tampa FL
Prostate cancer screening is typically recommended for men who are 55 years of age and older, as well as younger men who have one or more known risk factors. Physicians often offer prostate-specific antigen (PSA) screenings in addition to traditional digital rectal exams. Whether used together or separately, these tests can help detect abnormal changes early in their development.
If you’re concerned about your prostate cancer risk, or if you already had a PSA elevation or abnormal DRE or both, please contact our oncologists to discuss next steps. Because every man’s needs are different, our team can help each patient determine the prostate cancer screening methods (and frequency) that are most appropriate for his situation.
Abnormal screening results do not always mean that cancer is present. At Moffitt, we are committed to providing each patient with the careful evaluation necessary for an accurate diagnosis. Should a patient’s screening results indicate an elevated PSA level or the presence of a palpable growth in the prostate gland, we can provide a comprehensive range of follow-up tests, including:
- X-rays
- Computed tomography (CT) scans
- Magnetic resonance imaging (MRI)
- Transrectal ultrasounds
- Cystoscopies and bladder scope testing
- Prostate biopsies
Because these tests are provided by a team of oncologists who specialize in prostate cancer (and the results are interpreted by similarly specialized radiologists and pathologists), we are able to promptly provide our patients with the information they need and deserve.
Referrals are never necessary for prostate cancer care at Moffitt. To request an appointment, call 1-888-663-3488Â or submit a new patient registration form online. We welcome patients from Tampa, FL, all other nearby areas.
Prostate Cancer
- Acute Lymphocytic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia (APL)
- Adenocarcinoma
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Brain Metastases
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Chronic Lymphocytic Leukemia (CLL)
- Colon Cancer
- Colorectal Cancer
- Chronic Myeloid Leukemia (CML)
- Cutaneous Lymphoma (CTCL)
- Diffuse Large B-Cell Lymphoma
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Follicular Lymphoma
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- Clinical Trials
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Mantle Cell Lymphoma
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Non-Small Cell Lung Cancer
- Oral Cavity (Mouth) Cancer
- Insurance and Financial Information
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Small Cell Lung Cancer
- Smoldering Multiple Myeloma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer